Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2011
10/27/2011WO2011133811A2 Compositions, methods and kits to detect herpes simplex virus nucleic acid
10/27/2011WO2011133694A2 Method and apparatus for forming of an automated sampling device for the detection of salmonella enterica utilizing an electrochemical aptamer biosensor
10/27/2011WO2011133632A1 Separating target analytes using alternating magnetic fields
10/27/2011WO2011133625A1 Two-color chromogenic in situ hybridization
10/27/2011WO2011133609A2 Methods and kits to predict therapeutic outcome of btk inhibitors
10/27/2011WO2011133599A2 Physiological methods for isolation of high purity cell populations
10/27/2011WO2011133595A1 A polymer-nanostructure composition for selective molecular recognition
10/27/2011WO2011133581A1 Methods and compositions for assaying enzymatic activity of myeloperoxidase in blood samples
10/27/2011WO2011133538A1 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto
10/27/2011WO2011133529A1 Predictors of pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents
10/27/2011WO2011133500A2 Detection and analysis of epigenetic and genetic changes in tumor tissue
10/27/2011WO2011133477A2 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
10/27/2011WO2011133474A2 Methods of predicting predisposition to or risk of kidney disease
10/27/2011WO2011133453A2 Tray for tissue biopsy samples, methods of making, and methos of using thereof
10/27/2011WO2011133433A2 Real time pcr assay for detection of bacterial respiratory pathogens
10/27/2011WO2011133432A2 Methods to detect and isolate cancer stem cells
10/27/2011WO2011133424A2 Genetic amplification of iqgap1 in cancer
10/27/2011WO2011133327A1 Method for diagnosing melanocytic proliferations
10/27/2011WO2011133169A1 Dna intercalator detection
10/27/2011WO2011133056A1 Mutant strains of escherichia coli, a method of testing potential antibacterial agents using said strains as well as a testing kit
10/27/2011WO2011133051A1 Degenerated oligonucleotides and a method for molecular identification of ureolytic bacteria
10/27/2011WO2011133036A2 Means and methods for determining risk of cardiovascular disease
10/27/2011WO2011132989A2 Methylation marker for diagnosis of cervical cancer
10/27/2011WO2011132978A2 Fluorescence polarization analysis apparatus including dual light source
10/27/2011WO2011132977A2 Pcr device including two heating blocks
10/27/2011WO2011132872A2 Information providing method for diagnosis of tuberculosis, and tuberculosis diagnostic kit for same
10/27/2011WO2011132801A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof
10/27/2011WO2011132798A1 Novel dna methylation analysis method
10/27/2011WO2011132726A1 METHOD FOR PREPARING aRNA AND METHOD FOR ASSAYING GENE EXPRESSION
10/27/2011WO2011132667A1 Pcr test method which eliminates false-negatives, and primer used in the same
10/27/2011WO2011132587A1 Cell observation device and cell observation method
10/27/2011WO2011132586A1 Cell observation device and cell observation method
10/27/2011WO2011132584A1 Membrane potential change detection device and membrane potential change detection method
10/27/2011WO2011132480A1 Tetrazolium compound for detecting microorganisms, reagent for detecting microorganisms and method for detecting microorganisms
10/27/2011WO2011132392A1 Method for assaying histone methylation enzyme activity
10/27/2011WO2011132175A2 Novel biomarkers and targets for ovarian carcinoma
10/27/2011WO2011132078A2 Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing
10/27/2011WO2011132061A2 Methylation profiling of dna samples
10/27/2011WO2011131980A1 Assay for identification of lrrk2 inhibitors
10/27/2011WO2011131934A1 Ubiquitination assay
10/27/2011WO2011131808A1 Set of primers, method and kit for diagnosing and typing the pathogenic bacteria that cause olive knot, pseudomonas savastanoi pv. savastanoi
10/27/2011WO2011131774A1 Genetic factors associated with inhibitor development in hemophilia a
10/27/2011WO2011131713A1 Methods for predicting an antibody response to interferon therapy in multiple sclerosis patients
10/27/2011WO2011131685A1 Analytical applications of enzymatic growth of fluorescent quantum dots
10/27/2011WO2011131600A1 Nucleic acid sequences of a fish virus and the use thereof
10/27/2011WO2011131472A1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
10/27/2011WO2011131360A2 Method of determining the metastatic potential of a tumor
10/27/2011WO2011131354A1 Complex mirna sets as novel biomarkers for an acute coronary syndrome
10/27/2011WO2011131246A1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
10/27/2011WO2011131193A1 Diagnosing and treating fibrotic diseases using micro-rna 17
10/27/2011WO2011131192A1 New nucleotide sequence amplification method
10/27/2011WO2011131151A1 Liquid chip for detecting pik3ca gene mutations
10/27/2011WO2011131149A1 Liquid chip for detecting kras gene mutation
10/27/2011WO2011131146A1 Specific primers and liquid chips for detecting braf gene mutation
10/27/2011WO2011131145A1 Liquid chip for detecting egfr gene mutations
10/27/2011WO2011131128A1 Marker for colon cancer and method for detecting colon cancer
10/27/2011WO2011130880A1 Detection method of fetal chromosomal aneuploidy
10/27/2011WO2011130858A1 Method for the identification of t cell epitopes
10/27/2011WO2011130789A1 Tethered enzyme mediated nucleic acid detection
10/27/2011WO2011097301A3 METHODS AND COMPOSITIONS FOR PREDICTING RESPONSIVENESS TO TREATMENT WITH TNF-α INHIBITOR
10/27/2011WO2011088149A3 Methods for predicting response of triple-negative breast cancer to therapy
10/27/2011WO2011084387A3 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
10/27/2011WO2011081421A9 Complement c9 as markers for the diagnosis of cancer
10/27/2011WO2011072205A3 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin)
10/27/2011WO2011071956A3 Method for identification of protease activity inhibitors and assaying the presence of protease activity
10/27/2011WO2011066467A3 Allelic ladder loci
10/27/2011WO2011065729A3 Biosensor
10/27/2011WO2011057160A3 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
10/27/2011WO2011049322A3 Method for detecting methylation of breast cancer-specific methylation marker gene for breast cancer diagnosis
10/27/2011WO2011045570A3 Elisa signal amplification system using magnetic bead movement detection
10/27/2011WO2011044469A3 Diagnostic methods for oral cancer
10/27/2011WO2010099161A8 Micrornas in never-smokers and related materials and methods
10/27/2011WO2010003044A3 Epithelial layer detector and related methods
10/27/2011WO2002023190A8 Methods and products related to low molecular weight heparin
10/27/2011US20110265223 Functional analysis of jatropha curcas genes
10/27/2011US20110265219 Pepper hybrid ps09930066
10/27/2011US20110265199 Nucleotide sequences and polypeptides encoded thereby useful for increasing tolerance to oxidative stress in plants
10/27/2011US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
10/27/2011US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011US20110265193 Identification of mutation and method for detecting lavender foal syndrome in the horse
10/27/2011US20110265192 Nuclear receptor sensor system in transgenic animal
10/27/2011US20110264375 Computer-assisted means for assessing lifestyle risk factors
10/27/2011US20110263822 Composition for the prophylaxis and treatment of hbv infections and hbv-mediated diseases
10/27/2011US20110263697 Methods of Reducing Oxidative Modification of a Muscle Cell Protein
10/27/2011US20110263691 Methods concerning ppar delta and antagonists thereof
10/27/2011US20110263687 Rna molecules and uses thereof
10/27/2011US20110263685 Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
10/27/2011US20110263679 C12orf48 as a target gene for cancer therapy and diagnosis
10/27/2011US20110263677 Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011US20110263631 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
10/27/2011US20110263609 Methods of Identifying and Treating Individuals Exhibiting NUP214-ABL1 Positive T-Cell Malignancies with Protein Tyrosine Kinase Inhibitors and Combinations Thereof
10/27/2011US20110263585 Screening Assay for Insecticides
10/27/2011US20110263554 Screen for inhibitors of filovirus and uses therefor
10/27/2011US20110263523 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms
10/27/2011US20110263462 Methods and kits used in the detection of fungus
10/27/2011US20110263460 Compositions and methods for producing replication competent human immunodeficiency virus (hiv)
10/27/2011US20110263457 Multiplex Cellular Assays Using Detectable Cell Barcodes
10/27/2011US20110263456 Test element with nanofibers
10/27/2011US20110263453 Nucleic acid quantification products and processes
10/27/2011US20110263448 Interferon Response in Clinical Samples (IRIS)